Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )

NCT03748134 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

746

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

BIOLOGICAL: Sintilimab
DRUG: Cisplatin
DRUG: Paclitaxel
DRUG: Fluorouracil
DRUG: Placebo

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.

Collaborators

[object Object]